Abstract
Deamino-dicarba-oxytocin, a synthetic analogue of oxytocin in which both sulfur atoms are formally replaced by methylene moieties and the terminal amino group by a hydrogen atom, has been obtained as highly pure crystalline material. Upon bioassay this analogue exhibited 160 ± 4.4 units/mg of oxytocic activity, 44 ± 1.7 units/mg of avian vasodepressor activity, 140 ± 7 units/mg of rabbit milk-ejecting activity, 0.10 ± 0.02 unit/mg of rat pressor activity, and 4.7 ± 0.3 units/mg of rat antidiuretic activity.
Cumulative dose-response studies on the isolated rat uterus, mounted in magnesium-free van Dyke-Hastings solution, showed that the maximal attainable contractile response (intrinsic activity) of deamino-dicarba-oxytocin was only 68% of that of the natural oxytocic principle. Deamino-dicarba-oxytocin had a pD2 value (the negative logarithm of the concentration of the analogue that will evoke a half-maximal effect) of 8.35 ± 0.07; the pD2 value is a measure of time affinity of the analogue for its uterine receptor.
The presence of 0.5 mM Mg++ in the ambient fluid potentiated time contractile capacity of the uterus in response to deamino-dicarba-oxytocin; the intrinsic activity was increased by 35% over its original value.
Solutions in deamino-dicarba-oxytocin were found to be resistant to inactivation during lyophilization from water (pH 6) or aqueous triethylamine (pH ∼ 9).
ACKNOWLEDGMENTS We would like to thank Miss M. Wahrenburg and Mrs. I. Mintz for their highly skillful assistance in this study.
- Copyright ©, 1970, by Academic Press Inc.
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|